Nuveen’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nuveen’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.5M	Sell	62,060 -56,303	-48%	-$26.9M	0.01%	863
2025 Q4	$68.9M	Buy	118,363 +44,648	+61%	+$22.8M	0.02%	512
2025 Q3	$33.8M	Buy	73,715 +32,182	+77%	+$12M	0.01%	821
2025 Q2	$12.6M	Sell	41,533 -8,389	-17%	-$2.5M	﹤0.01%	1360
2025 Q1	$16.5M	Sell	49,922 -27,947	-36%	-$9.18M	0.01%	1244
2024 Q4	$24M	Sell	77,869 -11,125	-13%	-$3.13M	0.01%	1055
2024 Q3	$18.9M	Buy	88,994 +8,195	+10%	+$2.1M	0.01%	1231
2024 Q2	$22.6M	Buy	80,799 +10,087	+14%	+$2.4M	0.01%	1049
2024 Q1	$18.9M	Buy	70,712 +10,840	+18%	+$2.55M	0.01%	1218
2023 Q4	$13.9M	Buy	59,872 +20,337	+51%	+$3.56M	﹤0.01%	1382
2023 Q3	$5.77M	Sell	39,535 -8,927	-18%	-$1.68M	﹤0.01%	1788
2023 Q2	$11.2M	Buy	48,462 +12,236	+34%	+$3.31M	﹤0.01%	1441
2023 Q1	$8.78M	Sell	36,226 -544	-1%	-$148K	﹤0.01%	1564
2022 Q4	$2.35M	Buy	36,770 +1,549	+4%	+$151K	﹤0.01%	2305
2022 Q3	$2.29M	Buy	35,221 +205	+0.6%	+$14.2K	﹤0.01%	2335
2022 Q2	$2.51M	Buy	35,016 +1,887	+6%	+$139K	﹤0.01%	2323
2022 Q1	$3.14M	Sell	33,129 -23,585	-42%	-$1.99M	﹤0.01%	2293
2021 Q4	$4.05M	Sell	56,714 -9,567	-14%	-$786K	﹤0.01%	2237
2021 Q3	$5.42M	Buy	66,281 +6,013	+10%	+$519K	﹤0.01%	2159
2021 Q2	$5.87M	Buy	60,268 +28,627	+90%	+$3.39M	﹤0.01%	2168
2021 Q1	$3.7M	Sell	31,641 -30	-0.1%	-$3.5K	﹤0.01%	2320
2020 Q4	$3.52M	Sell	31,671 -1,720	-5%	-$210K	﹤0.01%	2246
2020 Q3	$3.96M	Buy	33,391 +260	+0.8%	+$28.2K	﹤0.01%	2045
2020 Q2	$3.75M	Sell	33,131 -2,721	-8%	-$268K	﹤0.01%	2055
2020 Q1	$2.39M	Buy	35,852 +2,679	+8%	+$223K	﹤0.01%	2104
2019 Q4	$3.02M	Sell	33,173 -682	-2%	-$66.1K	﹤0.01%	2240
2019 Q3	$2.92M	Buy	33,855 +1,304	+4%	+$122K	﹤0.01%	2230
2019 Q2	$3.41M	Buy	+32,551	New	+$3.49M	﹤0.01%	2183